Layoffs are coming at uBiome, a microbiome-testing startup under widespread scrutiny for allegedly engaging in improper billing practices, according to an internal email sent Thursday by the company’s interim CEO. The email did not specify how many employees would be laid off, nor when the cuts would happen.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,